Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BENAZEPRIL 10 MG — DIN 02290340

BENAZEPRIL HYDROCHLORIDE : 10 MG · AA PHARMA INC · TABLET · wholesale supply in Canada

Health Canada status: MARKETED

BENAZEPRIL 10 MG TABLET - DIN 02290340
BENAZEPRIL — DIN 02290340. Product photograph held by Nexara Health.

What is BENAZEPRIL?

BENAZEPRIL 10 MG contains BENAZEPRIL HYDROCHLORIDE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02290340, held by AA PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 25-Jun-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is BENAZEPRIL used for?

Treatment of mild to moderate essential hypertension. May be used alone or with thiazide diuretics. Not recommended for congestive heart failure or renovascular hypertension.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

How much does Benazepril cost around the world?

Benazepril is listed on 6 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Greece publishes a producer price (ex-factory); Italy publishes a prezzo al pubblico (classe A); Morocco publishes a PPV (public price). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
United Statesacquisition448USD███.██
Italyprezzo al pubblico (classe A)45EUR███.██
Saudi Arabiapublic33SAR███.██
Greeceproducer price (ex-factory)22EUR███.██
MoroccoPPV (public price)12MAD███.██
South Africasingle exit price22ZAR███.██

62 pack listings across 16 brand entries and 6 price bases, refreshed 05 Sep 2026. Ranges span every Benazepril pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Benazepril in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

3 holders have a Canadian DIN containing Benazepril, across 9 DINs, of which 3 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
AA PHARMA INC33BENAZEPRILSourceable in Canada
NOVARTIS PHARMACEUTICALS CANADA INC30LOTENSIN 10MG, LOTENSIN 20MG, LOTENSIN 5MGNo marketed DIN
PHARMASCIENCE INC30PMS-BENAZEPRILNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label10 MG
Dosage formTABLET
RouteORAL
Pack configuration (monograph)Bottles of 100 tablets.
StorageNot explicitly detailed in provided text (Section 11 header present but content missing), though typically room temperature for this class.

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substanceBenazepril
ATC codeC09AA07
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02290340
DIN (unpadded, as printed on some documents)2290340
Brand nameBENAZEPRIL
Generic / active ingredientBENAZEPRIL HYDROCHLORIDE : 10 MG
Market authorization holderAA PHARMA INC
Health Canada schedulePrescription
ATC codeC09AA07
ATC anatomical main groupC — Cardiovascular system
ATC therapeutic subgroupC09AA
Current statusMARKETED
Status date25-Jun-2012
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

How is it administered?

Initial: 10 mg once daily. Maintenance: 20 mg daily. Max: 40 mg/day. Adjust for renal impairment (CrCl < 30 mL/min: start at 5 mg). Correct volume/salt depletion before starting.

Included because it drives pack selection and wastage. Consult the monograph.

Contraindications

Hypersensitivity to benazepril or ACE inhibitors; history of angioedema; pregnancy/breastfeeding; concomitant use with neprilysin inhibitors or aliskiren (in diabetes/renal impairment).

Warnings and precautions

Serious: Fetal injury/death; risk of renal failure in susceptible patients. Warnings: Angioedema (can be fatal), hypotension, hyperkalemia, neutropenia, and cough.

Is Benazepril in shortage in Canada?

A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by AA PHARMA INC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for BENAZEPRIL

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

3 of 9 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
BENAZEPRIL20 MGTABLETAA PHARMA INCMARKETED02273918
BENAZEPRIL5 MGTABLETAA PHARMA INCMARKETED02290332
LOTENSIN 10MG10 MGTABLETNOVARTIS PHARMACEUTICALS CANADA INCCANCELLED POST MARKET00885843
LOTENSIN 20MG20 MGTABLETNOVARTIS PHARMACEUTICALS CANADA INCCANCELLED POST MARKET00885851
LOTENSIN 5MG5 MGTABLETNOVARTIS PHARMACEUTICALS CANADA INCCANCELLED POST MARKET00885835
PMS-BENAZEPRIL20 MGTABLETPHARMASCIENCE INCCANCELLED PRE MARKET02231551
PMS-BENAZEPRIL10 MGTABLETPHARMASCIENCE INCCANCELLED PRE MARKET02231550
PMS-BENAZEPRIL5 MGTABLETPHARMASCIENCE INCCANCELLED PRE MARKET02231548

2 · Same class — other molecules in ATC C09AA

MoleculeCanadian brandsDINsMarketedSourceable
RamiprilACH-RAMIPRIL &middot; ACT RAMIPRIL &middot; AG-RAMIPRIL &middot; ALTACE &middot; +37 more17155Yes
PerindoprilAG-PERINDOPRIL &middot; AG-PERINDOPRIL ERBUMINE &middot; APO-PERINDOPRIL &middot; APO-PERINDOPRIL ARGININE &middot; +20 more8154Yes
EnalaprilACT ENALAPRIL &middot; APO-ENALAPRIL &middot; AVA-ENALAPRIL &middot; DOM-ENALAPRIL &middot; +21 more10036Yes
TrandolaprilAPO-TRANDOLAPRIL &middot; AURO-TRANDOLAPRIL &middot; MAVIK &middot; MYLAN-TRANDOLAPRIL &middot; +4 more4025Yes
LisinoprilACT LISINOPRIL &middot; APO-LISINOPRIL &middot; APO-LISINOPRIL TABLET (TYPE P) - 10MG &middot; APO-LISINOPRIL TABLET (TYPE P) - 20MG &middot; +28 more9915Yes
CaptoprilAPO-CAPTO TAB 100MG &middot; APO-CAPTO TAB 12.5MG &middot; APO-CAPTO TAB 25MG &middot; APO-CAPTO TAB 50MG &middot; +41 more779Yes
CilazaprilAPO-CILAZAPRIL &middot; CILAZAPRIL &middot; CO CILAZAPRIL &middot; DOM-CILAZAPRIL &middot; +7 more336Yes
FosinoprilAPO-FOSINOPRIL &middot; AVA-FOSINOPRIL &middot; FOSINOPRIL &middot; FOSINOPRIL TABLETS &middot; +14 more326Yes
QuinaprilACCUPRIL 5MG TAB &middot; ACCUPRIL TAB 10MG &middot; ACCUPRIL TAB 20MG &middot; ACCUPRIL TAB 40MG &middot; +7 more326Yes
BenazeprilBENAZEPRIL &middot; LOTENSIN 10MG &middot; LOTENSIN 20MG &middot; LOTENSIN 5MG &middot; +1 more93Yes

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is BENAZEPRIL called?

Also recorded in Canada as: benazepril hydrochloride 2.5 MG / spironolactone 20 MG Chewable Tablet [Cardalis] (US), benazepril hydrochloride 5 MG / spironolactone 40 MG Chewable Tablet [Cardalis] (US), benazepril hydrochloride 10 MG / spironolactone 80 MG Chewable Tablet [Cardalis] (US), amlodipine 10 MG / benazepril hydrochloride 20 MG Oral Capsule [Lotrel] (US), amlodipine 10 MG / benazepril hydrochloride 40 MG Oral Capsule [Lotrel] (US), amlodipine 5 MG / benazepril hydrochloride 10 MG Oral Capsule [Lotrel] (US), amlodipine 5 MG / benazepril hydrochloride 20 MG Oral Capsule [Lotrel] (US), benazepril hydrochloride 10 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Lotensin HCT] (US), benazepril hydrochloride 20 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Lotensin HCT] (US), benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet [Lotensin HCT] (US), benazepril hydrochloride 10 MG Oral Tablet [Lotensin] (US), benazepril hydrochloride 20 MG Oral Tablet [Lotensin] (US), benazepril hydrochloride 40 MG Oral Tablet [Lotensin] (US), benazepril hydrochloride 5 MG Oral Tablet [Lotensin] (US), benazepril hydrochloride 2.5 MG / spironolactone 20 MG Chewable Tablet (US).

The same molecule, Benazepril, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
CIBACENLatinMorocco
CibaceLatinSouth Africa
Cibadrex FctLatinSouth Africa

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for BENAZEPRIL

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02290340. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.